chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax 12AUG96 & that same day pt devel fever of greater than 100;pt was taken to hosp where exp 3 febrile sz;pt was given shot to stop the sz;pt adm to intensive care unit overnoc & needed special attention all noc;
Pox on leg and face, Fever (101 deg F), tired. Pox remained for 5 days. Treatment childrens Motrin.
Excruciating pain in arms; Tingling in fingers; Can not close fingers; Can not sleep; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN IN EXTREMITY (Excruciating pain in arms), PARAESTHESIA (Tingling in fingers), MUSCULOSKELETAL STIFFNESS (Can not close fingers) and INSOMNIA (Can not sleep) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010821A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (Excruciating pain in arms), PARAESTHESIA (Tingling in fingers), MUSCULOSKELETAL STIFFNESS (Can not close fingers) and INSOMNIA (Can not sleep). The patient was treated with CYCLOBENZAPRINE for Adverse event, at a dose of 1 dosage form; LIDOCAINE for Adverse event, at a dose of 5 % patch and PREDNISONE for Adverse event, at a dose of 20 mg. At the time of the report, PAIN IN EXTREMITY (Excruciating pain in arms), PARAESTHESIA (Tingling in fingers), MUSCULOSKELETAL STIFFNESS (Can not close fingers) and INSOMNIA (Can not sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other Treatment details included Intravenous (IV) pain medication.  No concomitant medications were reported.
I have experienced Vertigo Since receiving the Vaccination, I have not been able to leave my home or go to work, because my Vertigo is so bad.
Father standing next to pt. Pt sitting in chair, and slid to floor with head laying in chair seat, pale skin. Laid her into floor flat and applied erol towels to face. Pt vomited rolled to R side. BP 90/50. Pulse 80. Responsive.
mom states recv vax 15FEB99 & 17FEB visit thigh was swollen x2 in size, hot to touch & area of possible inj site was excoriated from scratching;rx augmentin possible cellulitis;
45 y.o. received pediatric dose for Hep A, noted prior to patient leaving the facility Pediatric dose was given. Patient can receive another Pediatric dose if the error is discovered on the same clinic day. Patient agreed to receive a 2nd Pediatric dose before leaving the facility to equate to one adult dose.
pt recvd vax; devel red raised area of approx 2.5cm coincident w/ vax;
Red Bumps; Itching; Soreness; A spontaneous report was received from a consumer concerning a female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain (soreness), injection site erythema (red bumps) and pruritus (itching).  On 25 Feb 2021, approximately 9 days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025J20A) through an unknown route for prophylaxis of COVID-19 infection.   On 25 Feb 2021, after vaccination, the patient experienced soreness. On 6 Mar 2021, the patient stated experiencing injection site itchy and had red bumps.  No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event, soreness was resolved on 26 Feb 2021. The outcome of other events was unknown.
Patient is feeling nauseous about 15 after taking. The vaccine. Patient is diabetic. Snack provide. Called 911 patient is about to be ltransfered to the hospital.
This spontaneous report was received from patient of unknown age and gender reporting on him/herself. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, frequency, route and lot # were not provided). No concomitant therapies were reported. In 2012 the patient experienced shingles (herpes zoster). Then, on an unknown date the patient experienced post herpetic neuralgia - primary, blepharoedema, right (eyelid oedema), blepharochalases of right upper eyelid, limited to breakdown of skin (skin disorder) and skin ulceration. The patient had one consultation appointment with the clinic eye doctor already. He would have an upcoming appointment in July. The outcome of shingles, post herpetic neuralgia, skin disorder, eyelid oedema, blepharochalases and skin ulcer was unknown. The relationship between the events and ZOSTAVAX was not reported. Additional information has been requested.
I woke up on the morning of April 14, 2021, eight days after my first dose of the Moderna vaccine, with a small red, swollen rash on my left arm around the injection site. Over the course of the last 26 hours it's gotten larger and redder. It's hot to the touch, itchy, and my arm aches. I believe it's delayed cutaneous hypersensitivity (covid arm). Prior to this event I had not experienced any vaccine side effects since April 8, 2021 (the general sore, stiff arm everyone gets).
2 days after May 26th 4th dose of Pfizer  on May 28th both hands became numb/tingling and are still that way today.  It is constant not intermittent.  Since then on June 26th I am having weakness in legs an unstable in walking/balance issues in addition to the numbness of my hands.  Dr. advised to take vitamin B12 which. Have taken every day 500 mcg since June 1 however it hasn't improved.  B12 levels have increased though from 302 to 400.  Liver enzymes were also elevated and TSH Thyroid was elevated
sick; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via Global Digital Media through social media on 23-Nov-2020.  This case involves a patient of unknown demographic who experienced sick (malaise), while the patient was treated with INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), concomitant therapy, past vaccination(s) and family history were not provided.  On an unknown date, the patient received suspect influenza vaccine produced by unknown manufacturer (lot number and expiry date not reported) at an unknown dose via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date (latency: unknown) after starting the suspect vaccine therapy, the patient got sick (malaise) every time when got the suspect vaccine.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of the reporting , event outcome was unknown .  There will be no information available on batch number for this case .
Pt experienced swelling, erythema and pain at injection site. Fever of 102F, chills, malaise, axillary pain. Later the pts temperature was 99.9F and  pt had induration 10 X 12 cm left deltoid. ??????????
I experienced Fatigue, chest tightness, and increased blood pressure the first 2 days. Day 5 I started having pain in my upper back, left side. The next day had increased discomfort and developed a rash. Today, it is extremely painful and spread from the upper back to across my left  breast. My PCP agrees that it is Shingles. I am beginning a course of Valtex today, to lesson the severity of symptoms.
Woke up  the morning after the shot not feeling well, very nauseous.  Eventually threw up several times.  Remained tired through out the day and ran a low grade fever. By the evening developed the chills and felt like I could not get warm.  Went to bed early and slept 12 hours.  Did get extremely warm during the night. Next day felt better but still very tired and lacked my usually energy.  Things started to feel back to normal by Sunday evening.
Pt c/o lightheaded, elevated BP 180/98. Pt was seated, given snack and water. Felt betterand was discharged 20 minutes later
Site: Pain at Injection Site-Medium, Systemic: arm pain; radiates down to hand-Medium, Additional Details: Patient states she noticed pain the day after receiving vaccination and state her arm "has not felt right" since. She said she can hardly move her arm and it is very sore and she also has trouble using her right hand.
muscle atrophy; Initial information received on 12-Jan-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves an unknown age female patient who experienced muscle atrophy ,while receiving vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (dose, formulation, lot number not reported via unknown route in arm)  as prophylactic vaccination.  On an unknown date, the patient developed a non-serious event " muscle atrophy" (unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  It was reported"I have a question with regards to a potential event that I would like to discuss and potential report if it falls into this category. My wife went to the doctor yesterday about an issue with her arm. The doctor said it was likely caused by the way the a vaccine was administrated. The last vaccine she received was Flublok and they said it was given to high in her arm and has caused muscle atrophy. She was given the vaccine at a sanofi clinic. She also received covid vaccines but that was before she received her flu shot and the doctor said if it was administered where the atrophy occurred it was given way to high and was the cause. I would like to talk through this as I am not sure it qualifies or not but I wanted to report it once becoming aware and I also have a few other questions."  Action taken with QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK QIV) was not applicable.  It was not reported if the patient received a corrective treatment for the event (muscle atrophy).  At time of reporting, the outcome was Unknown for the event muscle atrophy.
10 min. after administration patient developed anaphylaxis rash, swelling of eyes, lips and site of injection, cough, wheezing and irritability. Received Epinephrine, BENADRYL and Dexamethasone. Was taken by ambulance to ER.
Usual blood sugars test began to run HI by about 60 mg/dl.; This is a spontaneous report from a contactable consumer (patient). A 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in right arm on 04Mar2021 (Batch/Lot Number: EN6205) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included hypertension, Heart By-Pass surgery in Jun2019. if other vaccine in four weeks: No. if covid prior vaccination: No. if covid tested post vaccination: No. No known allergies. Concomitant medication(s) (in two weeks) included insulin glargine (LANTUS) taken for an unspecified indication, start and stop date were not reported; metformin hydrochloride, sitagliptin (JANUMET [METFORMIN HYDROCHLORIDE; SITAGLIPTIN]) taken for an unspecified indication, start and stop date were not reported; repaglinide (PRANDIN) taken for an unspecified indication, start and stop date were not reported; losartan taken for an unspecified indication, start and stop date were not reported; carvedilol (COREG) taken for an unspecified indication, start and stop date were not reported; aspirin acetylsalicylic acid (ASPIRIN [ACETYLSALICYLIC ACID]) taken for an unspecified indication, start and stop date were not reported. Historical Vaccine included BNT162B2 (Product: COVID 19, brand: Pfizer Biontech, lot number: EL9262, lot unknown: False) (dose number: 1) on 11Feb2021 12:30 PM in right arm for covid-19 immunisation. The patient experienced usual blood sugars test began to run hi by about 60 mg/dl (non-serious) on 04Mar2021 20:00.  Adverse event: within 6 hours my usual blood sugars test began to run HI by about 60 mg/dl. Adverse event start date 04Mar2021 08:00 PM. Treatment was received for the adverse event. AE treatment: Patient have adjusted his Medications in hope of improvem. Facility type vaccine: Other. Facility country. The patient underwent lab tests and procedures which included blood sugars: began to run hi by about 60 mg/dl on 04Mar2021. The outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
Mother states that her son received the Varivax vaccine. Several months later, in June of 99 he developed shingles. This diagnosis was confirmed by his pediatrician. He son has developed shingles or zoster again as of March 6, 2000. This diagnosis was also confirmed by childs pediatrician.
Stomach ache, overall not feeling well, trouble breathing, pale lips and face, crying, fever of 100.  Fell into a deep sleep several hours later.  Could not reach Central Dist. Health to report.
Patient started feeling itching of the tongue 20 minutes after the injection. Stabilized, discharged to home.
Information has been received from a nurse concerning a 65 year old female patient who, on unspecified date, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the patient developed a very large circular rash accompanied with swelling at the injection site. The nurse stated "In the last month, this is more than she has seen historically." At the time of the report, the outcome of the patient was unknown. No product quality complaint was involved. This is one of two reports from the same source. Additional information has been requested.
Burning throat within minutes of receiving vaccine lasting 1-2 minutes.; Hot pressure on face and drooping eyes 45 minutes after vaccine lasting 5-10 minutes.; Hot pressure on face and drooping eyes 45 minutes after vaccine lasting 5-10 minutes.; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 24Apr2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 03Apr2021 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 13:00, within minutes of receiving vaccine, the patient experienced burning throat lasting 1-2 minutes and hot pressure on face and drooping eyes 45 minutes after vaccine lasting 5-10 minutes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events burning throat, hot pressure on face and drooping eyes was recovered on 24Apr2021.   No follow-up attempts are possible. No further information is expected.
L upper anterior arm (injection site) rash, was a little itchy and burning.  Pt reports no reaction immediately after the vaccines.
Information has been received from a health professional concerning a "young" female who was vaccinated with Gardasil (date of vaccination unknown). Subsequently, following the vaccination the patient lost her color, slumped over and almost fainted. Additional information has been requested.
Swelling, redness and pain; redness extending from under axilla, back of arm to just above the elbow. Area warm to the touch.
On 9/22/21 I (unknowingly) erroneously ordered rotavirus and it was inadvertently administered IM instead of PO by MA in-training during child's 4 month well child visit the morning of 9/22/21. MA reported to me shortly after child and parent left the office.  I immediately called for medical information. I realized the following day  (9/23/21) child was older than 14 weeks and should not have ordered first dose of rotavirus (child is catching up on 2-month immunizations). I  contacted infant's mother to inform on 9/23/21 around 5:15pm. Mother reported slight injection site swelling on both thighs.
Initial report was received from a health care professional on 3/20/06. A four year old female pt developed a softball sized area of redness, swelling, warmth and soreness at the injection site, one day after receiving Tripedia, lot number U1635CA, expiry date 2/12/07, and Ipol lot number Y0638 on 3/13/06. The pt received in concomitant the injection of MMR II, lot number 0466R. Route of administration and injection site for all vaccines was not reported. Per reporter, the pt denies any illness at the time of vaccination. The reaction occurred at the injection site of Tripedia. Treatment was not reported. At the time of this report the pt has not recovered. Follow up information received on 4/10/06. Per reporter, the pt received the IM injection of Tripedia dose 5 in the upper left arm, the SC injection of Ipol dose 5 in the lower left arm and the SC injection of MMR II dose 5 in the right arm. The swelling at the deltoid was larger than 1/2 dollar, warm and red. Treatment included cool compresses, Tylenol Q4H and Benadryl Q6H, Per reporter the pt recovered. NO further information expected. The reporter for this case is the same as for cases 200600653 and 200600654.
10-10 redness at injection site, my cervical lymph nodes were hot, hard painful, like 3 rocks by my collar bone.  10-12 all that plus all the lymph nodes swollen in my armpit!  Hurts to put my arm at my side.  General feeling of malaise continues. 10-13 lymph nodes still swollen and painful. Never had a reaction before...
Mom states Lt arm warm, swollen, red, hard at injection site after 24h. Site itchy. Mom declined bringing child in TBS. 1st time vaccines have been given in deltoids.
Rec'd varicella and FLUZONE R arm 12/15/2008.  Mother reports today an area " 3"x4", that is warm, red, hard and rashy" at the injection site R arm.
Became weak on Monday 12/28/20 in the evening and fell off the chair . Was semi-unconscious for 5 minutes . When I came to my wife took my BP 88/60 . I felt weak that evening and  went to bed early. I woke up fine that next day. No symptoms since.  No  medical follow required,
Information has been received from a medical assistant concerning a male patient with no known allergies who "this week (approximately 9/10/01) was vaccinated with a dose of pneumococcal vaccine 23 polyvalent in the arm. Subsequently, the patient developed a hot, swollen arm in the same arm as the injection site. The patient did not seek medical attention. Additional information has been requested.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 12-DEC-2017, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N021475 and expiration date 31-JAN-2020) for prophylaxis (Incorrect product storage). No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018   was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709:
I received my 3rd shot of Moderna on 11-8-21 and on 11-10-21 I started to develop shortness of breath, and severe chest pains. I was sent to the ER and was diagnosed with Pulmonary Embolism due to the vaccine. I now am being treated for several tiny blood clots on my lungs, and my heart is having a hard time pumping blood out due to the clots. I have been put on Xarelto a blood thinner.
In November 2021, 3 months after 3rd dose vaccine, I started noticing abdominal bloating and constipation. I just felt full and miserable. The next month, December 2021, I was having discomfort with aching to my lower right side and it felt like a ball was there. On 4-28-2022, I went to see my primary care doctor and told her of my symptoms and she prescribed metoclopramide to help me go to the bathroom. On May 19, 2022, I was having increased pain in my lower right side. I went to the local emergency room and the doctor thought I may be having gallbladder issues so he ordered an ultrasound of abdomen which showed normal. He also ordered blood work and ordered a HIDA scan to be done at a later date. They gave me IV fluids, fentanyl, REGLAN and TORADOL. They also told me to take ibuprofen and TYLENOL as needed. 6-2-2022, I had the HIDA scan which showed GB factor is 14% abnormally low. When the results of the HIDA scan came back, my primary care doctor called me and wanted to send me to a general surgeon to have the gallbladder removed but I had asked if I could just change my diet and lose weight because I don't want surgery. On 6-7, I went to go see a gastric specialist who wanted to do a colonoscopy but I did not choose to do that. My results of the HIDA scan was not back and ready at this time. The discomfort to my right lower abdomen is a 5-6 on a pain scale. I have lost 47 pounds since December 2021.
Headache; dizziness; taste of metal in mouth; heaviness in chest/tightness in chest; sore arm; This is a spontaneous report from a contactable consumer. This 67-Year-Old female consumer (patient) reported that: A 67-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EN6200), via an unspecified route of administration, administered in Arm Left on 20Feb2021 (at the age of 67-year-old) as single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included stable tiny right apical nodule and allergy to sulfa drugs and Penicillin. Patient not diagnosed with covid-19 prior to vaccination. Patient was not received any other vaccine four weeks prior vaccination. Patient received unspecified medication two weeks prior vaccination. The patient experienced Headache, dizziness, taste of metal in mouth, sore arm, tightness in chest and heaviness in chest on 07Feb2021. Since vaccination patient not tested for covid-19. No therapeutic measures were taken as a result of the events. The outcome of the events was reported as not recovered.  Follow-up attempts completed. No further information expected.
The caller has a hard time seeing so I am not 100% sure that she read the lot number correctly to me.  My arm hurt me really bad and my armpit hurt really bad. This started a couple of hours after receiving the injection. This lasted about 2 days. I noticed the red spots (bright red and flat) about noon on Friday. They are still there and have not changed since then.